Related Experiment Video
Updated: Jun 21, 2026

Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16
Published on: July 15, 2019
A B-box 2 surface patch important for TRIM5alpha self-association, capsid binding avidity, and retrovirus restriction
Felipe Diaz-Griffero1, Xu-rong Qin, Fumiaki Hayashi
1Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.
Abstract:
TRIM5alpha is a tripartite motif (TRIM) protein that consists of RING, B-box 2, coiled-coil, and B30.2(SPRY) domains. The TRIM5alpha(rh) protein from rhesus monkeys recognizes the human immunodeficiency virus type 1 (HIV-1) capsid as it enters the host cell and blocks virus infection prior to reverse transcription. HIV-1-restricting ability can be eliminated by disruption of the B-box 2 domain. Changes in the TRIM5alpha(rh) B-box 2 domain have been associated with alterations in TRIM5alpha(rh) turnover, the formation of cytoplasmic bodies and higher-order oligomerization. We present here the nuclear magnetic resonance structure of the TRIM5 B-box 2 domain and identify an unusual hydrophobic patch (cluster 1) on the domain surface. Alteration of cluster 1 or the flanking arginine 121 resulted in various degrees of inactivation of HIV-1 restriction, in some cases depending on compensatory changes in other nearby charged residues. For this panel of TRIM5alpha(rh) B-box 2 mutants, inhibition of HIV-1 infection was strongly correlated with higher-order self-association and binding affinity for capsid complexes but not with TRIM5alpha(rh) half-life or the formation of cytoplasmic bodies. Thus, promoting cooperative TRIM5alpha(rh) interactions with the HIV-1 capsid represents a major mechanism whereby the B-box 2 domain potentiates HIV-1 restriction.
Insights
The TRIM5alpha protein
Area of Science:
- Virology
- Molecular Biology
- Structural Biology
Background:
- TRIM5alpha (tripartite motif protein) is a key antiviral factor.
- Rhesus TRIM5alpha (TRIM5alpha(rh)) restricts human immunodeficiency virus type 1 (HIV-1) infection by recognizing the viral capsid.
- The B-box 2 domain of TRIM5alpha is crucial for its HIV-1 restricting ability.
Purpose of the Study:
- To elucidate the structural and functional role of the TRIM5alpha B-box 2 domain in HIV-1 restriction.
- To investigate how mutations in the B-box 2 domain affect TRIM5alpha's interaction with the HIV-1 capsid and its antiviral activity.
Main Methods:
- Nuclear magnetic resonance (NMR) spectroscopy was used to determine the structure of the TRIM5 B-box 2 domain.
- Site-directed mutagenesis was employed to create TRIM5alpha(rh) B-box 2 mutants.
- HIV-1 infection assays were performed to assess the antiviral activity of the mutants.
- Analysis of TRIM5alpha(rh) turnover, cytoplasmic body formation, and self-association was conducted.
Main Results:
- The NMR structure revealed an unusual hydrophobic patch (cluster 1) on the TRIM5 B-box 2 domain surface.
- Mutations in cluster 1 or at arginine 121 significantly impaired HIV-1 restriction.
- HIV-1 inhibition correlated strongly with higher-order self-association and capsid binding affinity.
- TRIM5alpha(rh) half-life and cytoplasmic body formation were not directly linked to antiviral activity.
Conclusions:
- The B-box 2 domain's ability to promote cooperative TRIM5alpha(rh) interactions with the HIV-1 capsid is a primary mechanism for restricting viral infection.
- Specific structural features, like the hydrophobic patch, are critical for TRIM5alpha's antiviral function.
- Understanding these interactions could inform strategies to enhance TRIM5alpha-mediated antiviral defense.
Related Concept Videos
Inhibitors of Virion Maturation and Assembly
Retroviruses
Retrovirus Life Cycles
Inhibitors Of Virion Release
Viral Structure
Inhibitors of Viral Protein Synthesis

